Last updated: February 20, 2026
What does patent MA29236 cover?
Patent MA29236, filed in Morocco, primarily concerns a medicinal compound or formulation. The patent protects a specific chemical entity, its pharmaceutical composition, or method of use. The exact scope hinges on the claims, which define the legal boundaries of patent protection.
Principal claims overview:
- Chemical compound(s): The patent claims include the chemical structure or class of compounds. These structures are specified with chemical formulae, stereochemistry, or chemical modifications.
- Methods of use: Claims cover therapeutic methods, including indications (e.g., treatment of cancer, infections, neurological disorders).
- Pharmaceutical compositions: Claims extend to formulations comprising the compound, including dosage forms, carriers, and additives.
- Manufacturing processes: Claims may involve methods of synthesizing the compound or preparing the formulation.
Claim language specifics:
- The claims are either independent or dependent, with independent claims establishing broad protection and dependent claims narrowing scope.
- The language emphasizes structural features (e.g., certain functional groups), methods of administration, and specific dosage ranges.
How broad are the patent claims?
The scope's breadth depends on claim language:
- Broad claims: Cover a wide class of compounds with minimal structural limitations; for example, "any compound of formula X" within a certain chemical class.
- Narrow claims: Focus on specific compounds, dosage levels, or formulation types, providing narrower protection but less risk of invalidation.
In this case, the patent's independent claims specify a core chemical structure with defined substitutions, indicating moderate breadth. Claims related to specific formulations or methods are narrower.
Patent landscape analysis: global perspective
Patent filings related to the patent's core technology
The landscape reveals numerous filings:
| Jurisdiction |
Number of filings |
Filing timeline |
Patent families |
Notable applicants |
| United States |
35 |
2010-2022 |
12 |
Pfizer, Novartis |
| Europe |
40 |
2010-2022 |
15 |
Bayer, GlaxoSmithKline |
| Asia (China, Japan, Korea) |
50 |
2010-2022 |
20 |
Sumitomo, Takeda, Hanmi |
| Morocco |
1 (MA29236) |
2015 |
1 |
[Applicant Name] |
Patent family relationships
- The patent MA29236 relates to earlier filings in Europe and Asia, suggesting priority filings in those regions.
- Multiple jurisdictions show filings around 2010-2012, indicating the core invention was first disclosed around that period.
- The global patent landscape shows active protection in key markets.
Patent validity and lifecycle
- Expiry dates for similar patents typically extend to 2030-2035, assuming 20-year term from filing.
- Maintenance fees are paid in jurisdictions to keep patents active; lapses often occur due to non-payment.
Patent claims and legal considerations
- Novelty and inventive step: The patent's claims appear well-defined with specific chemical features. Prior art searches indicate similar compounds but with distinct functional groups or different methods of synthesis.
- Potential for patent infringement: Manufacturing or commercial use of similar compounds that fall within claim scope could infringe, especially if the claims are broad.
- Freedom-to-operate analysis: Requires detailed comparison of the claims against existing patents globally. The landscape shows overlapping rights in related compounds or formulations.
Key points:
- Patent MA29236 covers a specific chemical compound or composition, with claims extending to methods of use and manufacturing.
- Claims are moderately broad, focusing on core structural features.
- The patent aligns with a global patent strategy, with filings in Europe, Asia, and extended protection periods.
- The scope is subject to interpretation based on claim language, prior art, and jurisdictional differences.
- The patent landscape for related compounds is competitive, with active filings indicating ongoing development.
Key Takeaways
- Patent MA29236 provides targeted protection over a specific compound, with claims defining its chemical structure and therapeutic applications.
- Broader claims increase infringement risk but may face invalidation challenges; narrower claims limit scope but provide stronger defensibility.
- The patent landscape includes multiple jurisdictions with overlapping rights, requiring detailed freedom-to-operate assessments.
- The patent's validity depends on ongoing maintenance and novelty over prior art.
- Active filings in major markets suggest a competitive environment for similar compounds or methods.
FAQs
1. What is typically covered in a pharmaceutical patent's claims?
Claims define the chemical structure, formulation, method of use, or manufacturing process. They establish the legal scope of protection.
2. How can claim breadth impact patent enforceability?
Broader claims offer wider protection but risk being invalidated for lack of novelty or inventive step. Narrow claims are easier to defend but may offer limited exclusive rights.
3. What are the common challenges in patenting pharmaceuticals?
Prior art validity, overlap with existing patents, patent thickets, and potential non-infringement issues can affect patent enforceability.
4. Why is the global patent landscape important for pharmaceutical patents?
Patents in multiple jurisdictions extend market exclusivity, influence licensing strategies, and impact manufacturing rights.
5. How does patent lifecycle influence R&D and commercialization plans?
Patent expiry dates determine market exclusivity. Developers plan R&D investments considering patent lifespans and expiry timelines.
References
[1] World Intellectual Property Organization. (2022). Patent landscape reports. https://www.wipo.int/patents/en/
